TokenPost·
ADC Therapeutics Revenue Climbs 32.9% to $21 Million in Third Quarter
Revenue beat estimates by $1.93 million, while the company posted a non-GAAP loss of $0.06 per share.
More news
- TokenPostAnthony Pompliano Repeats Bitcoin (BTC) Money-Printing Claim as U.S. M2 Rises
- TokenPostRB Global Raises 2026 Gross Transaction Value Growth Outlook
- TokenPostCoincheck Swings to $26.3 Million Quarterly Loss as Revenue Falls 43%
- TokenPostLong Liquidations Reach $642.2 Million Across Three Crypto Exchanges
- CryptopolitanIs Trump Media’s $410M profit more about Bitcoin than business?
- TokenPostLifeStance Prices 45 Million-Share Secondary Offering at $13.12